Manager, Independent Medical Education, CV, Metabolics and Oncology

SUMMARY

Passionate and forward-thinking Independent Medical Education (IME) manager qualified by robust and versatile experiences with launch brands (Apixaban, Dapagliflozin), Joint Alliance partners (Astra-Zeneca, Sanofi-Aventis, Pfizer), U.S./Global medical matrix teams within Cardiovascular (Atherosclerosis, Thrombosis), Metabolics (Type II Diabetes) and Oncology (Chronic Myelogenous Leukemia), as well as vendor and budget management.

Organized problem-solver with analytic skills to assess unmet needs, anticipate emerging issues and continuously adapt educational plans according to dynamic internal and external environments.

Demonstrated track record of developing and executing strategic initiatives with innovative vision, perseverance and ability to communicate effectively across management levels and disciplines.

CORE COMPENTENCIES AND KEY ACCOMPLISHMENTS

IME Strategic Planning and Execution

Collaborate with Alliance partners and U.S./Global to assist in developing 3-5 year IME strategic plans with defined educational goals, HCP prioritization and effective modalities.

Lead weekly grant review committee, provide recommendations to approve/deny grants based on educational and clinical alignment, and manage budgets of all grants up to $50K.

Track IME program development, activity updates and educational outcomes as well as monitor live events to evaluate educational impact.

Assess educational quality and effectiveness of approved programs by evaluating HCP participation, faculty engagement, program content and outcomes to identify educational gaps and/or need for Request for Proposals (RFPs).

Develop relationships with professional medical societies, academic centers, medical education providers and other pharmaceutical industry supporters to assess capabilities and educational/medical strategies.

Identified IME landscape trends and potential educational opportunities by conducting competitive benchmarking analysis of other commercially-supported IME programs through publically-available transparency reports.

Development of IME Value Proposition and Communication

Design a pilot initiative with Medical Science Liaisons (MSLs) and Regional Associate Directors (RADs) to work collaboratively and facilitate opportunities for MSLs to attend live events, provide feedback and allow IME to better understand local area needs.

Inform stakeholders of approved IME grants and outcomes on a quarterly basis.

Train medical new hires on IME processes and procedures.

Serve as IME lead to ensure coordination and communication of all IME activities which are related to priority key scientific congresses.

Proposed rationale and successfully obtained $200K for support live local IME diabetes programs for 2H2011 (original 2011 budget – $0).

Conducted in-depth interviews with multiple stakeholders (Commercial, Legal, Medical and Senior Leadership) in order to develop more effective tailored communication strategies.

Outside-the-Box Thinking and Visionary Leadership

Play a key role on the core team to promote an Advanced Practitioner (AP) customer model and partner with Market Research and MSLs to identify needs and preferences in order to deliver a superior customer experience.

Led a 10-month cross-functional medical strategy team and interface with Commercial and Global teams to prepare for a major diabetes competitor launch.

Supported a customer-focused initiative called ‘Customers at Center (c@c)’ on an ePharma work stream to identify novel sources of technology and social media for potential communication platforms to be used by medical matrix teams.

Established first-ever 5-week Pharm.D. student IME rotation with three schools of pharmacy and served as primary preceptor to four students to date.

Developed a 10-week MBA internship to create a ‘Return on Education (ROE)’ model.

Increased membership of women’s leadership organization called ‘Women in Science (WIS)’ by 3-fold as a core team member by enhancing networking opportunities for women employees.

Process Improvement and Efficiencies

Create IME brochure to be used as a reactive MSL resource.

Lead a cost benchmarking analysis of IME programs to determine cost-competitiveness and implement cost controls.

Spearhead initiative to optimize reporting capabilities of grant database.

Standardized department-wide IME reports to provide insights, outcomes and strategic recommendations for Customer Facing Sub-Team (CFaST) work stream.

PROFESSIONAL EXPERIENCE

2010 – Present Bristol-Myers Squibb Plainsboro, NJ

Manager, Independent Medical Education, CV/Met and Oncology

2009 – Present Vizzoni’s Pharmacy Trenton, NJ

Staff Pharmacist (Part-time)

2009 – 2010

Bristol-Myers Squibb Plainsboro, NJ

Rutgers Pharmaceutical Industry Fellowship

Post-Doctoral Fellow, Independent Medical Education, Metabolics

EDUCATION

2003 – 2009 University of the Sciences in Philadelphia Philadelphia, PA

Philadelphia College of Pharmacy

Doctor of Pharmacy

TEACHING EXPERIENCE

2009 – 2010 Rutgers, The State University of New Jersey Piscataway, NJ

Ernest Mario School of Pharmacy

Adjunct Faculty Member

PUBLICATIONS AND POSTERS

March 2010 Choi JH, McCollough M. Community pharmacy practice employers’ and pharmacy students’ perceptions on the current community pharmacy practice job market in this state survey reveal attitudes that can reflect a mirror of the current climate. Pharmacy Careers (a Pharmacy Times publication). Spring 2010;17.

March 2010 Choi JH, McCollough M, Feudo DM, Patel R, Volino L. Community pharmacy practice employers’ and pharmacy students’ perceptions on the current community pharmacy practice job market. Poster session presented at: APhA2010 Annual Meeting and Exposition; 2010 Mar 12-15; Washington, DC.

December 2009 Choi JH, McCollough M, Feudo DM, Patel R, Volino L. Community pharmacy practice employers’ and pharmacy students’ perceptions on the current community pharmacy practice job market. Poster session presented at: 44th ASHP Midyear Clinical Meeting and Exhibition; 2009 Dec 6-10; Las Vegas, NV.

LICENSES AND CERTIFICATIONS

2009 – Present New Jersey Board of Pharmacy (License No. 28RI03326000) and APhA Immunization Administration

PROFESSIONAL AFFILIATIONS

Present

2011 – Present

2003 – Present Hematology/Oncology Pharmacy Association (HOPA)

Healthcare Businesswomen’s Association (HBA)

American Pharmacists Association (APhA), American Society of Health-System Pharmacists (ASHP)

Contact this candidate